Institutional Investor Sentiment About West Pharmaceutical Services Inc (NYSE:WST) Increased

October 2, 2018 - By Ash

West Pharmaceutical Services, Inc. (NYSE:WST) Logo

Sentiment for West Pharmaceutical Services Inc (NYSE:WST)

West Pharmaceutical Services Inc (NYSE:WST) institutional sentiment decreased to 0.95 in 2018 Q2. Its down -0.13, from 1.08 in 2018Q1. The ratio dived, as 119 active investment managers started new and increased positions, while 125 decreased and sold their positions in West Pharmaceutical Services Inc. The active investment managers in our partner’s database now possess: 71.57 million shares, up from 67.31 million shares in 2018Q1. Also, the number of active investment managers holding West Pharmaceutical Services Inc in their top 10 positions increased from 1 to 2 for an increase of 1. Sold All: 32 Reduced: 93 Increased: 76 New Position: 43.

West Pharmaceutical Services, Inc. manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company has market cap of $8.93 billion. The companyÂ’s Proprietary Products segment offers stoppers and seals for injectable packaging systems; and syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. It has a 60.74 P/E ratio. It also provides drug containment solutions, including CZ vials, syringes, and cartridges; and self-injection systems, as well as specialized testing services for drug packaging, devices, and administration systems.

The stock decreased 1.33% or $1.64 during the last trading session, reaching $121.36. About 44,001 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 28.92% since October 2, 2017 and is uptrending. It has outperformed by 13.30% the S&P500.

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on October, 25. They expect $0.72 earnings per share, up 7.46 % or $0.05 from last year’s $0.67 per share. WST’s profit will be $52.95 million for 42.14 P/E if the $0.72 EPS becomes a reality. After $0.70 actual earnings per share reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts 2.86 % EPS growth.

Kistler holds 2.31% of its portfolio in West Pharmaceutical Services, Inc. for 52,418 shares. Ami Asset Management Corp owns 292,016 shares or 2.07% of their US portfolio. Moreover, Sandhill Capital Partners Llc has 1.84% invested in the company for 117,153 shares. The Colorado-based Rk Capital Management Llc has invested 1.37% in the stock. Hermes Investment Management Ltd, a United Kingdom-based fund reported 968,945 shares.

Since January 1, 0001, it had 1 buying transaction, and 3 selling transactions for $9.11 million activity.

West Pharmaceutical Services, Inc. (NYSE:WST) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News